Literature DB >> 2982304

Hypercalcemia and disseminated cytomegalovirus infection in the acquired immunodeficiency syndrome.

G P Zaloga, B Chernow, C Eil.   

Abstract

Two patients with the acquired immunodeficiency syndrome and disseminated cytomegalovirus infection developed hypercalcemia associated with suppressed parathyroid gland activity. Neither patient had evidence of a malignant, endocrinologic, granulomatous, or drug-related cause for hypercalcemia. Increased osteoblastic bone resorption induced by cytomegalovirus infection may have been the cause for the hypercalcemia. Physicians should be alert for the occurrence of endocrinologic and metabolic problems in immunosuppressed patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2982304     DOI: 10.7326/0003-4819-102-3-331

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  6 in total

1.  The acquired immunodeficiency syndrome and hypercalcemia.

Authors:  M B Jacobs
Journal:  West J Med       Date:  1986-04

Review 2.  Electrolyte and acid-base disorders associated with AIDS: an etiologic review.

Authors:  M A Perazella; E Brown
Journal:  J Gen Intern Med       Date:  1994-04       Impact factor: 5.128

3.  Disorders of serum calcium in acquired immunodeficiency syndrome.

Authors:  S A Peter
Journal:  J Natl Med Assoc       Date:  1992-07       Impact factor: 1.798

Review 4.  Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis.

Authors:  P Chrisp; S P Clissold
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

5.  Opportunistic intraocular infections in AIDS.

Authors:  E N Morinelli; P U Dugel; M Lee; E C Klatt; N A Rao
Journal:  Trans Am Ophthalmol Soc       Date:  1992

6.  Viral infections in the acquired immunodeficiency syndrome.

Authors:  S E Miller; D N Howell
Journal:  J Electron Microsc Tech       Date:  1988-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.